°ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼

This 2-day conference is the third of its kind. It will provide an update on the current status for biosimilars in EU and internationally with focus on both regulatory and scientific challenges as well as market access and experiences. Patients and physicians approach to use of biosimilars will be part of the conference scope including a discussion on biosimilars adoption into current treatment guidelines in EU. The conference will consist of plenary lectures followed by interactive panel discussions providing participants an opportunity to bring forward their own experience and share their thoughts and ideas with the experts.

Featured Topics
Current regulatory status of biosimilars in the EU
International development of biosimilars
Naming of biologicals including biosimilars
Pharmacovigilance issues related to biosimilars – EU and globally
Market experience with biosimilars including market access and pricing
Patient and physicians approach to use of biosimilars

This conference is aimed at intermediate and experienced professionals from:
Regulatory agencies
The pharmaceutical industry and service providers including
Regulatory affairs personnel
Pharmacovigilance staff
Clinical and medical personnel
Academic institutions
Physicians and their scientific societies
Patients organisations

Learning Objectives
Deal with regulatory requirements, scientific and operational challenges
Exchange experiences and discuss Hot Topics with experts
Update the participant on the current knowledge including regulatory and scientific thinking
Discuss pros and cons of Biosimilars